Ecubectedin, CAS [[2248127-53-7]]

Produktübersicht

• Artikelname: Ecubectedin, CAS [[2248127-53-7]]
• Artikelnummer: MCE-HY-139570
• Hersteller Artikelnummer: HY-139570
• Alternativnummer: MCE-HY-139570-10MG,MCE-HY-139570-5MG,MCE-HY-139570-1MG,MCE-HY-139570-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: PM14

Produktbeschreibung

Ecubectedin (PM14) is an anticancer agent. Ecubectedin downregulates the expression of MDM2, thereby stabilizing and activating p53, it inhibits Bax/Bcl-2 and activates Caspase-3, ultimately inducing apoptosis. Ecubectedin exerts dual effects of direct killing and immunoregulation by inducing DNA damage, activating the innate immune signaling pathway (cGAS/STING) and triggering immunogenic cell death. Ecubectedin can be used in research related to human liver cancer and malignant pleural mesothelioma[1][2].

Produkteigenschaften

• Molekulargewicht: 784.87
• Reinheit: 99.59
• CAS Nummer: [2248127-53-7]
• Formel: C41H44N4O10S
• Target-Kategorie: Apoptosis,Bcl-2 Family,Caspase,DNA/RNA Synthesis,MDM-2/p53,STING

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound